NEW YORK, Feb 21 - Zygogen of Atlanta will provide Curis with its
proprietary transgenic zebrafish technology for use in genomics-based drug
discovery, Zygogen said Wednesday.

Zebrafish are similar to knockout mice in that they can serve as model
organisms for finding genome-based drug targets, but they offer the
advantage of being faster to breed and less expensive.

Zygogen, founded in 1999, uses Z-Tag, a technology through which it can
design transgenic zebrafish with organs that are labeled and cell lineages

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.